Abnormal Myocardial Enzymes are Important Indicators of Poor Prognosis in COVID-19 Patients
Open Access
- 7 April 2021
- journal article
- research article
- Published by Taylor & Francis in Future Virology
- Vol. 16 (4) , 265-276
Abstract
Objective: Researching the prognostic value of myocardial enzymes in COVID-19 patients. Materials & methods: We collected 113 confirmed COVID-19 patients. The dynamic changes of CK, LDH and α-HBDH ...Keywords
This publication has 20 references indexed in Scilit:
- The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active MetabolismEndocrine, Metabolic & Immune Disorders - Drug Targets, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2Cardiovascular Research, 2020
- Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside WuhanClinical Infectious Diseases, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting systemic lupus erythematosus with liver injuryInternational Immunopharmacology, 2019
- Creatine kinase myocardial band - a biomarker to assess prognostically relevant periprocedural myocardial infarctionInternational Journal of Cardiology, 2018